APA (7th ed.) Citation

NHK, N., R, R., A, T., A, S., A, L., AK, d. J. S., . . . JK, L. (2023). Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML. Blood advances, 7(9), 1769. https://doi.org/10.1182/bloodadvances.2022007934

Chicago Style (17th ed.) Citation

NHK, Nguyen, et al. "Genome-wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML." Blood Advances 7, no. 9 (2023): 1769. https://doi.org/10.1182/bloodadvances.2022007934.

MLA (9th ed.) Citation

NHK, Nguyen, et al. "Genome-wide CRISPR/Cas9 Screen Identifies Etoposide Response Modulators Associated with Clinical Outcomes in Pediatric AML." Blood Advances, vol. 7, no. 9, 2023, p. 1769, https://doi.org/10.1182/bloodadvances.2022007934.